Immunocore (IMCR) Insider Trading & Ownership $36.31 +0.10 (+0.28%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$36.29 -0.02 (-0.06%) As of 07/18/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Immunocore (NASDAQ:IMCR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage10.40%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$23.99MNumber OfInsiders Selling(Last 12 Months)0 Get IMCR Insider Trade Alerts Want to know when executives and insiders are buying or selling Immunocore stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address IMCR Insider Buying and Selling by Quarter Immunocore Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/17/2025Bros. Advisors Lp BakerDirectorBuy807,338$29.72$23,994,085.36 (Data available from 1/1/2013 forward) IMCR Insider Trading Activity - Frequently Asked Questions Who is on Immunocore's Insider Roster? The list of insiders at Immunocore includes Bros. Advisors Lp Baker, and Leger Tina Amber St. Learn more on insiders at IMCR. What percentage of Immunocore stock is owned by insiders? 10.40% of Immunocore stock is owned by insiders. Learn more on IMCR's insider holdings. Which Immunocore insiders have been buying company stock? The following insider purchased IMCR shares in the last 24 months: Bros. Advisors Lp Baker ($23,994,085.36). How much insider buying is happening at Immunocore? Insiders have purchased a total of 807,338 IMCR shares in the last 24 months for a total of $23,994,085.36 bought. Which Immunocore insiders have been selling company stock? The following insider sold IMCR shares in the last 24 months: Leger Tina Amber St ($305,768.75). How much insider selling is happening at Immunocore? Insiders have sold a total of 4,375 Immunocore shares in the last 24 months for a total of $305,768.75 sold. Immunocore Key ExecutivesDr. Bahija Jallal Ph.D. (Age 63)CEO & Executive Director Compensation: $1.38MMr. Brian R. Di Donato M.B.A. (Age 57)Executive VP, CFO & Strategy Compensation: $654.46kMs. Tina St. Leger (Age 56)Chief Human Resources Officer Compensation: $509.12kDr. David Berman M.D. (Age 53)Ph.D., Executive Vice President of Research & Development Compensation: $796.62kMr. John Trainer M.B.A. (Age 50)SVP & Chief Operating Officer Mr. John Goll IIISVP, Finance & Chief Accounting OfficerMs. Annelise Vuidepot Ph.D.Senior VP, CTO and Research & UK Site LeadMr. Sean D. Buckley (Age 41)VP & Chief Information Officer Clayton RobertsonHead of Investor RelationsMs. Lily Margaret Hepworth (Age 41)Senior VP, General Counsel & Company Secretary More Insider Trading Tools from MarketBeat Related Companies Grifols Insider Ownership TG Therapeutics Insider Ownership Nuvalent Insider Ownership Lantheus Insider Ownership Axsome Therapeutics Insider Ownership CRISPR Therapeutics Insider Ownership ADMA Biologics Insider Ownership Vaxcyte Insider Ownership Rhythm Pharmaceuticals Insider Ownership Cytokinetics Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional SupportDo They Know Something? Insiders & Congress Buy UnitedHealth This page (NASDAQ:IMCR) was last updated on 7/20/2025 by MarketBeat.com Staff From Our PartnersBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunocore Holdings PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Immunocore With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
